AR and colorectal carcinoma: It was found that the high expression of reporter TF signatures (AR, GATA1, GATA2, GATA3, EST1, YBX1, PRADM14, ESR1, E2F4, and FOXP3) is associated with worse survival outcomes of the CRC patients.